Publications by authors named "Dieter Hoelzer"

216 Publications

Chemotherapy-free Treatment - A New Era in Acute Lymphoblastic Leukemia?

Authors:
Dieter Hoelzer

N Engl J Med 2020 10;383(17):1673-1674

From the University of Frankfurt, Frankfurt, Germany.

View Article and Find Full Text PDF
October 2020

Managing toxicities with asparaginase-based therapies in adult ALL: summary of an ESMO Open-Cancer Horizons roundtable discussion.

ESMO Open 2020 10;5(5):e000858

Jane Anne Nohle Division of Hematology, University of Southern California, Los Angeles, California, USA.

View Article and Find Full Text PDF
October 2020

Current status and future clinical directions in the prevention and treatment of relapse following hematopoietic transplantation for acute myeloid and lymphoblastic leukemia.

Bone Marrow Transplant 2019 01 31;54(1):6-16. Epub 2018 May 31.

Adult Stem Cell Transplant Program, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, 1501 NW 10th Avenue, Suite 916, Miami, FL, 33157, USA.

View Article and Find Full Text PDF
January 2019

Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin Lymphomas (PETAL): A Multicenter, Randomized Phase III Trial.

J Clin Oncol 2018 07 11;36(20):2024-2034. Epub 2018 May 11.

Ulrich Dührsen, Stefan Müller, Jan Dürig, Johannes Matschke, Christine Schmitz, Thorsten Pöppel, Andreas Bockisch, and Andreas Hüttmann, Universitätsklinikum Essen; Claudia Ose, Marcus Brinkmann, Karl-Heinz Jöckel, André Scherag, and Jan Rekowski, Universität Duisburg-Essen, Essen; Bernd Hertenstein and Henrike Thomssen, Klinikum Bremen Mitte; Christiane Franzius, Zentrum für moderne Diagnostik, Bremen; Jörg Kotzerke and Frank Kroschinsky, Universitätsklinikum Carl Gustav Carus; Gabriele Prange-Krex, Onkologische Gemeinschaftspraxis, Dresden; Rolf Mesters, Wolfgang E. Berdel, and Matthias Weckesser, Universitätsklinikum Münster, Münster; Dorothea Kofahl-Krause, Frank M. Bengel, and Lilli Geworski, Medizinische Hochschule Hannover, Hannover; Paul La Rosée, Martin Freesmeyer, and André Scherag, Universitätsklinikum Jena, Jena; Andreas Hertel and Heinz-Gert Höffkes, Klinikum Fulda, Fulda; Dirk Behringer, Augusta-Kranken-Anstalt, Bochum; Stefan Wilop and Thomas Krohn, Universitätsklinikum Aachen, Aachen; Jens Holzinger and Martin Griesshammer, Johannes Wesling Klinikum, Minden; Aristoteles Giagounidis, Helios St Johannes Klinik, Duisburg; Aruna Raghavachar, Helios Universitätsklinikum, Wuppertal; Georg Maschmeyer and Ingo Brink, Klinikum Ernst von Bergmann, Potsdam; Helga Bernhard, Klinikum Darmstadt, Darmstadt; Uwe Haberkorn, Universitätsklinikum Heidelberg, Heidelberg; Tobias Gaska, Brüderkrankenhaus St Josef, Paderborn; Lars Kurch, Universitätsklinikum Leipzig, Leipzig; Wolfram Klapper, Universitätsklinikum Schleswig-Holstein, Kiel; Dieter Hoelzer, Onkologikum, Frankfurt/Main, Germany; and Daniëlle M.E. van Assema, Vrije Universiteit Medical Center, Amsterdam, the Netherlands.

View Article and Find Full Text PDF
July 2018

"Society of Hematologic Oncology (SOHO) State of the Art Updates and Next Questions"-Treatment of ALL.

Clin Lymphoma Myeloma Leuk 2018 05 3;18(5):301-310. Epub 2018 Apr 3.

Onkologikum, Frankfurt am Museumsufer, Frankfurt, Germany. Electronic address:

View Article and Find Full Text PDF
May 2018

Lymphoblastic lymphoma.

Crit Rev Oncol Hematol 2017 May 18;113:304-317. Epub 2017 Mar 18.

San Raffaele Scientific Institute, Milan, Italy.

View Article and Find Full Text PDF
May 2017

Personalized medicine in adult acute lymphoblastic leukemia.

Authors:
Dieter Hoelzer

Haematologica 2015 Jul;100(7):855-8

Onkologikum Frankfurt am Museumsufer, Frankfurt, Germany

View Article and Find Full Text PDF
July 2015

Dose-adjusted EPOCH-R for Burkitt lymphoma.

Authors:
Dieter Hoelzer

Clin Adv Hematol Oncol 2014 Nov;12(11):777-9

Goethe University Hospital, Frankfurt, Germany.

View Article and Find Full Text PDF
November 2014

Phase II trial of the anti-CD19 bispecific T cell-engager blinatumomab shows hematologic and molecular remissions in patients with relapsed or refractory B-precursor acute lymphoblastic leukemia.

J Clin Oncol 2014 Dec 10;32(36):4134-40. Epub 2014 Nov 10.

Max S. Topp, Hermann Einsele, and Ralf C. Bargou, Universitätsklinikum Würzburg, Würzburg; Nicola Gökbuget, Goethe University; Dieter Hoelzer, Onkologikum, Frankfurt; Gerhard Zugmaier, Petra Klappers, and Noemi Mergen, Amgen Research; Dorothea Wessiepe, Metronomia, Munich; Matthias Stelljes, University of Münster, Münster; Svenja Neumann, Heinz-August Horst, and Monika Brüggemann, University Schleswig Holstein, City Hospital, Kiel; Andreas Viardot, University of Ulm, Ulm; Reinhard Marks, Universitätsklinikum Freiburg, Freiburg; Helmut Diedrich, Medizinische Hochschule Hannover, Hannover; Christoph Faul, Universitätsklinikum Tübingen, Tübingen; Albrecht Reichle, Universitätsklinikum Regensburg, Regensburg, Germany; and Chris Holland and Shilpa Alekar, Amgen, Rockville, MD.

View Article and Find Full Text PDF
December 2014